drug discovery

Exscientia lands multi-million euro deal with Bayer
By Leontina Postelnicu | 08:56 am | January 10, 2020
Bayer and Exscientia will initially work on three early-stage projects using AI to speed up drug discovery.
AI researcher Daphne Koller heading new machine learning drug discovery venture
By Dave Muoio | 05:35 pm | May 02, 2018
In a recent medium.
BenevolentAI gets $115M to harness AI for new drug discovery
By Jonah Comstock | 02:03 pm | April 20, 2018
BenevolentAI, a UK company using artificial intelligence for drug development, has raised $115 million in new funding, mostly from undisclosed investors in the United States.